DB16504ExperimentalSmall molecule
BCc1 is a nanomedicine that demonstrated potent anticancer effects in both in vitro and in vivo studies.
- Mechanism
- Curator reviewed
BCc1 is a nanocomplex with therapeutic effects that is designed based on nanochelating technology. It is currently being investigated against cancer.
- Code names
- BCc1
Resolves to
Targets
What you can answer from here — as of October 21, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with BCc1, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account